| Research Programme
in 2005
Grants Awarded in financial year 2005 (Total of £477,184) |
| A STUDY OF THE TECHNITIUM LABELLED BEMBESIN
ANALOGUE, DEMOBESIN-4, FOR IMAGING OF LYMPH NODE INVOLVMENT IN
PROSTATE CANCER. G2005/01 Mr Vinod Nargund PhD MS FRCS(Urol) FEBU, Professor Stephen
Mather |
|
| TRAINING IN LAPARASCOPIC SURGERY OF THE
PROSTATE G2005/02 Mr John Donohue |
|
| CRYO-ABLATION THERAPY TRIAL AND INVESTIGATION
INTO POST-TREATMENT QUALITY OF LIFE, MORBIDITY AND EFFICACY. G2005/03 Mr David Haines |
|
| PROTEOLYSIS INDUCING FACTOR AS A SURVIVAL
AND PROLIFERATION FACTOR IN PROSTATIC CARCINOMA CELLS AND ITS
POTENTIAL AS A FUTURE THERAPEUTIC TARGET. G2005/04 Mr Grant Stewart |
|
| INHIBITION OF THE MALIGNANT PROGRESSION
OF PROSTATE CANCER CELLS BY SUPPRESSING THE EXPRESSION OF THE
OSTEOPONTIN GENE. G2005/05 Professor Yougiang Ke |
|
| THE STUDY OF FIBROBLAST GROWTH FACTOR (FGF)
SIGNALLING MOLECULES IN DIAGNOSTIC PROSTATE CANCER BIOPSIES AS
PROGNOSTIC MARKERS FOR DISEASE PROGRESSION. G2005/06 Dr Vincent Gnanapragasam |
|
| THE EFFECTS OF ZOLEDRONIC ACID ON INTRA-CELLULAE
SIGNALLING PATHWAYS IN PROSTATE CANCER CELLS. G2005/07 Mr Tom Swallow |
|
| IDENTIFICATION OF NOVEL ANDROGEN RECEPTOR
INTERACTING PROTEINS INVOLVED IN RESPONSE TO PROSTATE CANCER
THERAPY. G2005/08 Dr Charlotte Bevan, Professor R.C. Coombes |
|
| SIRNA AND ANTISENSE OLIGONUCLEOTIDES AS
THERAPEUTIC UTILITIES FOR PROSTATE CANCER. G2005/09 Dr Bader Alem Usmani, Dr Ian Graham |
|
| THE ROLE OF CHROMOSONE TRANSLOCATION IN
THE PROGRESSION OF PROSTATE CANCER. G2005/10 Dr Yong-Jie Lu |
|
| DEVELOPMENT OF ONCOLYTIC ADENOVIRUSES FOR
TARGETING OF REFRACTORY PROSTATE CANCERS, ENHANCEMENT OF CYTOTOXICITY
BY COMBINATION THERAPIES. G2005/11 Dr Gunnel Halldén |
|
| A NEW SENSITIVE AND ACCURATE DIAGNOSTIC
TEST FOR PROSTATE CANCER. G2005/12 Dr Christiane Fenske |
|
| ENDOTHELIAL PROGENITOR CELLS AND CIRCULATING
ENDOTHELIAL CELLS IN PROSTATE CANCER. G2005/13 Dr Andrew Blann PhD FRCPath |
|
| ORGANISATIONAL DETERMINANTS OF PROSTATE
CANCER OUTCOMES. G2005/14 Professor Mark McCarthy |
|
| DEVELOPMENT OF AN EX-VIVO PROSTATE CANCER
MODEL FOR THE ASSESSSMENT OF THE SECOND GENERATION GENE THERAPY
FOR LOCALISED PROSTATE CANCER. G2005/15 Dr Daniel Ashdown |
|
| AN EVALUATION OF HEM-ABLATION THERAPY USING
HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) IN THE TREATMENT OF
LOCALISED ADENOCARCINOMA OF THE PROSTATE. G2005/16 Dr Mark Emberton |
|
| MOLECULAR GENETIC CHANGES IN PROSTATE CANCER:
GUIDES TO CLINICAL MANAGEMENT. G2005/17 Dr Mark Feneley |
|
| GRANTS FOR EDUCATIONAL PURPOSES TO VARIOUS
PERSONS AND/OR INSTITUTIONS. G2005/18 via Prostate Research Campaign UK |
|
Total Grants Awarded for Prostate Research in financial year 2005 is £477,184